中国新生儿筛查四十三年发展历程——从陈瑞冠教授说起
收稿日期: 2024-01-11
网络出版日期: 2024-02-02
The forty-three year development of newborn screening in china: starting with Chen Ruiguan
Received date: 2024-01-11
Online published: 2024-02-02
赵正言 . 中国新生儿筛查四十三年发展历程——从陈瑞冠教授说起[J]. 临床儿科杂志, 2024 , 42(2) : 89 -92 . DOI: 10.12372/jcp.2024.24e0027
After forty-three years of development, China’s newborn screening program has achieved remarkable success. Professor Chen Ruiguan, not only a pioneer in the field of newborn screening in China but also the founder of this discipline. This article comprehensively reviews the development of newborn screening in China, including the expansion of screened diseases and technological innovations, the promulgation of relevant national policies, the significant achievements of newborn screening, and its impact on families and society. It also looks ahead to future directions, commemorating Professor Chen’s outstanding contributions.
Key words: Chen Ruiguan; newborn screening; developmental history
[1] | 赵正言, 顾学范. 新生儿遗传代谢病筛查[M]. 北京: 人民卫生出版社, 2015. |
[2] | Grosse SD, Dezateux C. Newborn screening for inherited metabolic disease[J]. Lancet, 2007, 369(9555): 5-6. |
[3] | 占霞, 顾学范, 琳娜, 等. 串联质谱检测干血滤纸片多种溶酶体酶活性方法的建立[J]. 中华检验医学杂志, 2016, 39(10): 761-765. |
[4] | 李改杰, 田丽萍, 郭元芳, 等. 串联质谱法筛查新生儿溶酶体贮积症酶活性切值的建立[J]. 浙江大学学报(医学版), 2022, 51(3): 321-325. |
[5] | 蒋丽红, 杨茹莱, 赵正言, 等. 中国新生儿筛查进展[J]. 浙江大学学报(医学版), 2023, 52(6): 673-682. |
[6] | 中华预防医学会出生缺陷预防与控制专业委员会新生儿遗传代谢病筛查学组. 新生儿筛查遗传代谢病诊治规范专家共识[J]. 中华新生儿科杂志, 2023, 38(7): 385-394. |
[7] | 中华预防医学会出生缺陷预防与控制专业委员会新生儿遗传代谢病筛查学组. 新生儿遗传代谢病筛查组织管理及血片采集技术规范专家共识[J]. 中华新生儿科杂志, 2023, 38(6): 321-326. |
[8] | 中华预防医学会出生缺陷预防与控制专业委员会新生儿遗传代谢病筛查学组. 新生儿遗传代谢病筛查实验室检测技术规范专家共识[J]. 中华新生儿科杂志, 2023, 38(8): 449-454. |
[9] | 顾学范, 韩连书, 余永国. 中国新生儿遗传代谢病筛查现状及展望[J]. 罕见病研究, 2022, 1(1): 13-19. |
[10] | Jia C, Zhao D, Li Y, et al. Newborn screening and genomic analysis of duchenne muscular dystrophy in Henan, China[J]. Clin Chim Acta, 2023, 539: 90-96. |
[11] | Huang X, Wu D, Zhu L, et al. Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates[J]. Orphanet J Rare Dis, 2022, 17(1): 66. |
[12] | 中国研究型医院学会神经科学专业委员会, 中国出生缺陷干预救助基金会神经与肌肉疾病防控专项基金组织专家组. 脊髓性肌萎缩症新生儿筛查专家共识(2023版)[J]. 中华医学杂志, 2023, 103(27): 2075-2081. |
[13] | Chen T, Fan C, Huang Y, et al. Genomic sequencing as a first-tier screening test and outcomes of newborn screening[J]. JAMA Netw Open, 2023, 6(9): e2331162. |
[14] | Yang RL, Qian GL, Wu DW, et al. A multicenter prospective study of next-generation sequencing-based newborn screening for monogenic genetic diseases in China[J]. World J Pediatr, 2023, 19(7): 663-673. |
[15] | Hao C, Guo R, Hu X, et al. Newborn screening with targeted sequencing: a multicenter investigation and a pilot clinical study in China[J]. J Genet Genomics, 2022, 49(1): 13-19. |
/
〈 |
|
〉 |